Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 6 |
GO:0043226 | organelle | 2 | 6 |
GO:0043227 | membrane-bounded organelle | 3 | 6 |
GO:0043229 | intracellular organelle | 3 | 6 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0008023 | transcription elongation factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AID9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006354 | DNA-templated transcription elongation | 6 | 1 |
GO:0006368 | transcription elongation by RNA polymerase II | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0032774 | RNA biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043169 | cation binding | 3 | 7 |
GO:0046872 | metal ion binding | 4 | 7 |
GO:0000993 | RNA polymerase II complex binding | 5 | 1 |
GO:0001098 | basal transcription machinery binding | 3 | 1 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 4 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0019899 | enzyme binding | 3 | 1 |
GO:0043175 | RNA polymerase core enzyme binding | 5 | 1 |
GO:0070063 | RNA polymerase binding | 4 | 1 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003746 | translation elongation factor activity | 4 | 1 |
GO:0008135 | translation factor activity, RNA binding | 3 | 1 |
GO:0045182 | translation regulator activity | 1 | 1 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 122 | 126 | PF00656 | 0.552 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.614 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.411 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.353 |
CLV_PCSK_PC1ET2_1 | 4 | 6 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 60 | 62 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.622 |
DOC_CYCLIN_yCln2_LP_2 | 163 | 169 | PF00134 | 0.475 |
DOC_CYCLIN_yCln2_LP_2 | 67 | 73 | PF00134 | 0.411 |
DOC_MAPK_gen_1 | 60 | 67 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 33 | 40 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 66 | 75 | PF00069 | 0.411 |
DOC_PP2B_LxvP_1 | 163 | 166 | PF13499 | 0.722 |
DOC_PP4_FxxP_1 | 25 | 28 | PF00568 | 0.411 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.675 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.636 |
DOC_USP7_UBL2_3 | 14 | 18 | PF12436 | 0.411 |
LIG_14-3-3_CanoR_1 | 42 | 49 | PF00244 | 0.411 |
LIG_BRCT_BRCA1_1 | 214 | 218 | PF00533 | 0.490 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.512 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.411 |
LIG_LIR_Apic_2 | 16 | 22 | PF02991 | 0.411 |
LIG_LIR_Apic_2 | 23 | 28 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 211 | 218 | PF02991 | 0.641 |
LIG_LIR_Gen_1 | 59 | 70 | PF02991 | 0.513 |
LIG_LIR_Nem_3 | 211 | 217 | PF02991 | 0.608 |
LIG_LIR_Nem_3 | 59 | 65 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.322 |
LIG_REV1ctd_RIR_1 | 72 | 80 | PF16727 | 0.411 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.411 |
LIG_SH2_CRK | 214 | 218 | PF00017 | 0.641 |
LIG_SH2_NCK_1 | 121 | 125 | PF00017 | 0.514 |
LIG_SH2_STAP1 | 214 | 218 | PF00017 | 0.743 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.665 |
LIG_TRAF2_1 | 200 | 203 | PF00917 | 0.776 |
MOD_CK1_1 | 137 | 143 | PF00069 | 0.723 |
MOD_CK1_1 | 145 | 151 | PF00069 | 0.732 |
MOD_CK1_1 | 45 | 51 | PF00069 | 0.478 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.630 |
MOD_Cter_Amidation | 2 | 5 | PF01082 | 0.411 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.688 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.665 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.620 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.411 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.523 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.766 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.383 |
MOD_PKA_1 | 14 | 20 | PF00069 | 0.411 |
MOD_PKA_1 | 5 | 11 | PF00069 | 0.411 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.411 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.598 |
MOD_PKB_1 | 131 | 139 | PF00069 | 0.514 |
MOD_Plk_1 | 212 | 218 | PF00069 | 0.488 |
MOD_Plk_1 | 45 | 51 | PF00069 | 0.411 |
MOD_Plk_2-3 | 119 | 125 | PF00069 | 0.493 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.411 |
MOD_SUMO_for_1 | 13 | 16 | PF00179 | 0.411 |
MOD_SUMO_rev_2 | 26 | 35 | PF00179 | 0.411 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.641 |
TRG_ER_diArg_1 | 131 | 134 | PF00400 | 0.515 |
TRG_ER_diArg_1 | 49 | 52 | PF00400 | 0.350 |
TRG_NLS_MonoCore_2 | 3 | 8 | PF00514 | 0.411 |
TRG_NLS_MonoExtN_4 | 4 | 9 | PF00514 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 154 | 158 | PF00026 | 0.627 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HWX8 | Leptomonas seymouri | 61% | 94% |
A0A3Q8IBQ8 | Leishmania donovani | 81% | 100% |
A4HYT0 | Leishmania infantum | 82% | 100% |
E9AUM6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q4QCV8 | Leishmania major | 83% | 100% |